The white blood cell (WBC) count and serum C-reactive protein (CRP), immunoglobulin M (IgM), and procalcitonin (PCT) levels are commonly used as biomarkers for early-onset neonatal bacterial infections in clinical settings worldwide [4,5,6,7]. This evidence concerns the gene CD40LG and bacterial infectious disease.